Literature DB >> 22365169

Fluid overload assessment and management in heart failure patients.

Tertius Tuy1, W Frank Peacock.   

Abstract

Heart failure is a syndrome in which myocardial function is incapable of providing for normal physiologic needs. In the acute care setting, cardiac dysfunction primarily manifests with volume perturbations and presents with signs and symptoms of vascular congestion. Thus, in acute heart failure volume assessment is crucial in diagnosing and improving the prognosis. Also, goal-directed therapy relies on accurate volume assessment to minimize the adverse outcomes of inappropriate, ineffective, or excessive diuresis. Currently, in most institutions clinical methods of volume assessment are the mainstay. However, these methods are highly dependent on the practitioners' skill level. In fact, there is a high variability between experienced physicians when assessing volume. As adjuncts, objective methods of volume assessment are being developed and used such as natriuretic peptides, bioimpedance analysis, and imaging.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22365169     DOI: 10.1016/j.semnephrol.2011.11.014

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  9 in total

1.  Usefulness of combining admission brain natriuretic peptide (BNP) plus hospital discharge bioelectrical impedance vector analysis (BIVA) in predicting 90 days cardiovascular mortality in patients with acute heart failure.

Authors:  Simona Santarelli; Veronica Russo; Irene Lalle; Benedetta De Berardinis; Silvia Navarin; Laura Magrini; Antonio Piccoli; Marta Codognotto; Luigi Maria Castello; Gian Carlo Avanzi; Humberto Villacorta; Bernardo Luiz Campanário Precht; Pilar Barreto de Araújo Porto; Aline Sterque Villacorta; Salvatore Di Somma
Journal:  Intern Emerg Med       Date:  2016-12-16       Impact factor: 3.397

2.  Comparison of Respiratory Variations of Subclavian Vein and Inferior Vena Cava in Hospitalized Patients with Kidney Disease.

Authors:  Elaine M Kaptein; Alan Cantillep; John S Kaptein; Zayar Oo; Myint B Thu; Phyu Phyu Thwe; Matthew J Kaptein
Journal:  Int J Nephrol Renovasc Dis       Date:  2020-11-10

3.  Retraction. rhBNP therapy can improve clinical outcomes and reduce in-hospital mortality compared with dobutamine in heart failure patients: a meta-analysis.

Authors:  Ming-Yi Lv; Shu-Ling Deng; Xiao-Feng Long
Journal:  Br J Clin Pharmacol       Date:  2015-11-28       Impact factor: 4.335

4.  Fluid status and outcome in patients with heart failure and preserved ejection fraction.

Authors:  Benedikt Koell; Caroline Zotter-Tufaro; Franz Duca; Andreas A Kammerlander; Stefan Aschauer; Daniel Dalos; Marlies Antlanger; Manfred Hecking; Marcus Säemann; Julia Mascherbauer; Diana Bonderman
Journal:  Int J Cardiol       Date:  2016-12-21       Impact factor: 4.164

Review 5.  Focused Real-Time Ultrasonography for Nephrologists.

Authors:  Matthew J Kaptein; Elaine M Kaptein
Journal:  Int J Nephrol       Date:  2017-02-02

6.  Comparison of subclavian vein to inferior vena cava collapsibility by ultrasound in acute heart failure: A pilot study.

Authors:  Yvonne E Kaptein; Elaine M Kaptein
Journal:  Clin Cardiol       Date:  2021-12-21       Impact factor: 2.882

7.  A Smart-Phone App for Fluid Balance Monitoring in Patients with Heart Failure: A Usability Study.

Authors:  Zhiyun Shen; Yaping Zhang; Chun Yang; Jie Liu; Chenxu Huang; Xian Zhang; Yuxia Zhang; Ying Lin
Journal:  Patient Prefer Adherence       Date:  2022-08-02       Impact factor: 2.314

8.  The top tertile of hematocrit change during hospitalization is associated with lower risk of mortality in acute heart failure patients.

Authors:  Haobin Zhou; Tianyu Xu; Yuli Huang; Qiong Zhan; Xingfu Huang; Qingchun Zeng; Dingli Xu
Journal:  BMC Cardiovasc Disord       Date:  2017-09-02       Impact factor: 2.298

9.  Relationship of inferior vena cava collapsibility to ultrafiltration volume achieved in critically ill hemodialysis patients.

Authors:  Matthew J Kaptein; John S Kaptein; Zayar Oo; Elaine M Kaptein
Journal:  Int J Nephrol Renovasc Dis       Date:  2018-07-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.